STOP PRESS: Glaxo diabetes drug withdrawn from sale
Following the withdrawal of Glaxo Wellcome’s newest diabetes drug
Romozin (troglitazone), the PR campaign being run by Manning Selvage and
Lee has been suspended. Glaxo withdrew the drug after an increase in
liver problems was identified among users. Around 5,000 people in the UK
have been prescribed the drug since its launch two months ago. Glaxo is
handling crisis PR in-house.